Abstract
This chapter will discuss some remarkable examples of extremophilic bacteria, isolated from different ecosystems, which produce exopolysaccharides (EPSs). The chapter will also cover the properties of EPSs produced by extremophiles and their possible commercial applications ranging from pharmaceutical to food processing, detoxification and bioremediation. This chapter will also cover the techniques that are used to purify, analyse and structurally characterise the bacterial EPSs; the state of the art in the field of bacterial EPSs research, with mention to the main examples of well-studied and commercially exploited EPSs; an overview of the main EPSs’ producing extremophiles that have been isolated from both aquatic and terrestrial environments; the description of the main biosynthetic routes leading to the EPSs production in archaeal and bacterial extremophiles, with reference to the enzymes involved and to the genetic manipulations for biosynthesis’s tailoring; the analysis of the most interesting biological properties of extremophiles’ EPSs (that can act as anti-inflammatory, immunomodulating and antiviral agents) and of their biotechnological applications in drug delivery systems; and the compendium of the most used techniques to perform the purification, the analysis of chemical composition, the identification of glycoside linkage position and substitution pattern, the determination of the molecular-weight distribution and the structural analysis of EPSs.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
FormalPara What Will You Learn from This ChapterThis chapter will discuss some remarkable examples of extremophilic bacteria, isolated from different ecosystems, which produce exopolysaccharides (EPSs). The chapter will also cover the properties of EPSs produced by extremophiles and their possible commercial applications ranging from pharmaceutical to food processing, detoxification and bioremediation. This chapter will also cover the techniques that are used to purify, analyse and structurally characterise the bacterial EPSs; the state of the art in the field of bacterial EPSs research, with mention to the main examples of well-studied and commercially exploited EPSs; an overview of the main EPSs’ producing extremophiles that have been isolated from both aquatic and terrestrial environments ; the description of the main biosynthetic routes leading to the EPSs production in archaeal and bacterial extremophiles, with reference to the enzymes involved and to the genetic manipulations for biosynthesis’s tailoring; the analysis of the most interesting biological properties of extremophiles’ EPSs (that can act as anti-inflammatory, immunomodulating and antiviral agents) and of their biotechnological applications in drug delivery systems; and the compendium of the most used techniques to perform the purification, the analysis of chemical composition, the identification of glycoside linkage position and substitution pattern, the determination of the molecular-weight distribution and the structural analysis of EPSs.
10.1 Introduction
The exopolysaccharides (EPSs) are high-molecular-weight heterogeneous polymers composed by some most recurring monomers like hexoses, pentoses, uronic acids and amino sugars that are often substituted either by organic non-carbohydrate or inorganic groups. Some remarkable examples of well-studied and commercially exploited EPSs include xanthan gum (produced by Xanthomonas species), gellan (produced by bacteria belonging to Sphingomonas genus), alginate (found in bacteria from the genera Azotobater and Pseudomonas), hyaluronan (produced by different bacterial strains, e.g. Pseudomonas aeruginosa) and levan (produced by species of the genera Bacillus, Rahnella, Aerobacter, Erwinia, Streptococcus, Pseudomonas and Zymomonas and recently found also in a species of Halomonas genus) (Freitas et al. 2011). Several studies have described the production of large quantities of these polymers also by bacterial species living in extreme environments , for example, Antarctic marine environments or hydrothermal vents, where they are thought to complex with various metal ions and contribute to their mobility and entry into the food web (Mancuso Nichols et al. 2004 and references therein). Bacterial EPSs usually are found as biofilm, a complex mixture constituted by proteins, nucleic acids and lipids besides the polysaccharides. The bacterial species that are able to produce EPSs include several extremophiles, a group of microorganisms that have developed various adaptation strategies , enabling them to compensate for the deleterious effects of harsh environmental conditions such as high temperatures and salt concentrations, low pH or temperature and high radiation. Among these strategies, the EPS biosynthesis is one of the most common protective mechanisms. Exopolysaccharides can be found as in capsular material or as dispersed slime in the surrounding environment. Considerable progress has been made in discovering and developing new microbial EPSs that possess novel industrial significance. In recent years the increased demand for natural polymers for pharmaceutical, food and other industrial applications has led to a remarkable interest in polysaccharides produced by microorganisms (Poli et al. 2011; Finore et al. 2014; Nicolaus et al. 2010).
This chapter will give a short review of extremophilic microorganisms as a source of EPSs with particular attention to their production, structural characterisation methods and biological activities.
10.2 Examples of Archaeal and Bacterial EPS Producers and Their Biosynthetic Pathway
EPS-producing microorganisms have been isolated from different natural sources of both aquatic and terrestrial environments , as well as in extreme niches such as hot springs , cold, hypersaline and halophilic environments, such as salt lakes and salterns (Poli et al. 2009, 2010; Yasar Yildiz et al. 2014).
EPSs produced by extremophiles embody promising biotechnological applications: their rheological properties, biological activities, metal-binding capabilities and new sugar composition make these biopolymers suitable for many applications. Indeed their potential biotechnological spectrum of application is very wide, ranging from antiviral and thickening agents to bioflocculanting and viscosifying agents and from biosurfactant and bioemulsifier to vaccine adjuvants . Moreover, for their metal-binding and pollutant bioadsorption activities, EPSs could be employed in the bioremediation processes (Finore et al. 2014).
Microorganisms belonging to Bacteria and Archaea domains have been described as EPS producers: some representative examples are listed in Table 10.1. In the Archaea domain, Sulfolobus solfataricus strain MT4, Haloferax mediterranei, Haloferax gibbonsii and Haloarcula japonica strain T5 represent some example of species able to produce EPS for which the participation in biofilm formation and solid surface adhesion has been suggested (Poli et al. 2011). In the range of thermophilic EPS producers (Table 10.1), species like Thermus aquaticus strain YT-1, Thermotoga maritima and several species belonging to the Geobacillus genus (G. thermantarcticus strain M1, G. tepidimans strain V264, G. thermodenitrificans strain B3-72, Geobacillus sp. strain 4004) showed the EPS production . Moreover, species of Bacillus genus (such as B. licheniformis strain T4 isolated from a shallow hydrothermal vent of Panarea Island, Italy) and Aeribacillus genus (Aeribacillus pallidus strain 418 isolated from the Bulgarian Rupi hydrothermal springs) have been reported as responsible for the synthesis of novel EPSs, as shown in Table 10.1 (Kambourova et al. 2009; Nicolaus et al. 2010; Spanò et al. 2013 and references therein).
Pseudoalteromonas strain 721 isolated from deep-sea hydrothermal vents produced an EPS that exhibited gel formation and viscoelastic behaviour at increasing temperature . In the Antarctic and Arctic ecosystems (see also Table 10.1), Pseudoalteromonas sp. SM9913, Pseudoalteromonas strain CAM025 and CAM036 and Colwellia psychrerythraea strain 34H have been described as source of EPS from cold marine environments: in the case of Pseudoalteromonas CAM 025 and CAM036, sulphated heteropolysaccharides with high levels of uronic acids and acetyl groups have been described, and cryoprotection activities have been suggested (Mancuso Nichols et al. 2004 and references therein).
Saline soils collected from salterns and sediments from salt lakes represent the extreme niches in which halophiles EPSs producers have been isolated: some main examples are reported in Table 10.1. High sulphate content EPSs have been described for the EPSs produced by Halomonas maura strain S-30, Halomonas anticariensis strain FP35, Halomonas ventosae strain A112 and Halomonas eurihalina strain F2-7: for these two latters, the formation of stable emulsions has been also recorded (Poli et al. 2010 and references therein). Halomonas smyrnensis, isolated from a saltern area in Turkey, represents the first examples of levan producer Halomonas species (Poli et al. 2009). This microorganism could be considered an alternative cheap source of levan polymer for which bioflocculant properties in the treatment of industrial wastewaters have been described (Table 10.1). Levan from H. smyrnensis has been tried as a nano-carrier system for peptide and protein drugs delivery. Halomonas alkaliantarctica isolated from a salt lake in Antarctica produced a fructo-glucan polymer that presented a high viscosity at low pH values and at high NaCl concentration, resulting as a viscosity control agent in proposed biotechnological applications (Poli et al. 2010). Salipiger mucosus A3T (Table 10.1), a halophilic species belonging to the Alphaproteobacteria genus and isolated from the Spanish Mediterranean seaboard , produced an EPS rich of fucose that was synthesised essentially during the exponential phase growth (Llamas et al. 2010): the authors suggested its use as source of fucose in spite of fucose-rich polysaccharides usually extracted from brown algae with more laborious and expensive procedures. Zunongwangia profunda SM-A87 isolated from deep-sea sediment in southern Okinawa Trough is the first marine bacterium that produces EPS with the high yield of 8.90 g/L (Qin et al. 2010).
Bacterial polysaccharides are comprised of repeating units of sugar moieties, which are synthesised by a group of enzymes named ‘glycosyltransferases’. In some cases the EPS biosynthetic pathway is known, and the genetic manipulation has been employed in order to not only optimise the yield of EPS production but also to tailor the EPS chemical composition and structure. In fact, in addition to elucidation of biosynthesis mechanisms , it is possible to improve the microbial productivity via strain improvement strategies or to modify physicochemical and/or rheological properties of the biopolymer by changing its composition, length or degree of branching (Nicolaus et al. 2010). There are three main biosynthetic routes for microbial EPSs . The synthesis of some glucan- or fructan-type homopolysaccharides is carried out in the extracellular environment through the action of specifically secreted sucrase enzymes (Nicolaus et al. 2010). These glucansucrases and fructansucrases are glycoside hydrolases that act on sucrose and catalyse the transglycosylation reactions forming the polymer chain. Biosynthetic pathways of microbial heteropolysaccharides and of some homopolysaccharides are more complex and involve five distinct steps: (1) uptake of sugar subunits and their activation with a high-energy bond through their conversion into sugar nucleotides, (2) assembly of the repeating monosaccharide unit on an isoprenoid lipid carrier by sequential transfer of monosaccharides from sugar nucleotides by glycosyltransferases, (3) addition of any acyl groups, (4) polymerisation of the repeating unit and (5) secretion of the polysaccharide from the cell membrane into the extracellular environment. Despite the structural diversity of EPSs, there are only three mechanisms for the polymerisation, namely, ABC-transporter-dependent, synthase-dependent and the most commonly used wzy-dependent pathways (Nicolaus et al. 2010).
Analysis of the flanking regions of a mini-Tn5 insertion site in an EPS-deficient mutant of Halomonas maura strain TK71 led to the identification of five ORFs (epsABCDJ), which form part of a gene cluster (eps) with the same structural organisation as others involved in the biosynthesis of group 1 capsules and some EPSs. The possibility that mauran, the polysaccharide produced by H. maura, might be synthesised via a Wzy-like biosynthesis system is reported by Arco et al. (2005).
The genomes of three model extreme thermophiles , an archaeon, Pyrococcus furiosus (Topt of 98 °C), and two bacteria, Thermotoga maritima (Topt of 80 °C) and Caldicellulosiruptor saccharolyticus (Topt of 70 °C), encode numerous carbohydrate-active enzymes , many of which have been biochemically characterised in their native or recombinant forms. In Streptococcus thermophilus Sfi6 the biosynthesis of exopolysaccharides is regulated by eps gene cluster of 14.5-kb region comprised of 13 genes, namely, epsA to epsM (Stingele et al. 1996). Gene epsA located at the beginning of the cluster is involved in the regulation of EPS expression, and the central region (epsE, epsF, epsG, epsH and epsI) of the gene cluster is involved in the biosynthesis of the tetramer repeating unit. Gene epsE encodes the galactosyltransferase, catalysing the first step of biosynthesis of the repeating unit. Genes upstream (epsC and epsD) and downstream (epsJ and epsK) of the central region regulate polymerisation and export of the EPS (Stingele et al. 1996). In the case of Zunongwangia profunda SM-A87, its genome was the first sequenced in the phylum of Bacteroidetes (Qin et al. 2010). It possesses two polysaccharide biosynthesis gene clusters, and the genome analysis reveals its adaptation to the deep-sea environment and ecological role in sedimentary organic nitrogen degradation.
For a systems-based approach to the EPS biosynthetic pathways, microbial genome sequence is considered as a starting point, and from this point of view, next-generation sequencing (NGS) technologies play a significant role by enabling high-throughput genomic data at very high speed with a relatively low cost. When the whole-genome sequence of the EPS-producer microorganism is not available, sequence data of a taxonomically close species could also be used for systems-based studies . This approach has been used for the improvement of levan production by the halophilic strain Halomonas smyrnensis AAD6T, where first, the available whole-genome sequence of a taxonomically close microorganism, Chromohalobacter salexigens DSM 3043, was used to construct a comprehensive genome-scale metabolic model , and then this model was recruited and adopted to the producer strain via integration of the available biochemical, physiological and phenotypic features of H. smyrnensis AAD6T. With metabolic system analysis of this generic metabolic model, significant improvement in levan yields was obtained (Ateş et al. 2011, 2013).
Considering that the microbial biodiversity of marine and terrestrial ecosystems is relatively unexplored, it is reasonable to hypothesise that the isolation and identification of new microorganisms will provide wide opportunities for new industrial fields.
10.3 Most Remarkable Examples of Bioactive EPS
Natural bioactive polysaccharides isolated from several sources have attracted much attention in the field of biochemistry and pharmacology: indeed several polysaccharides or their glycoconjugates have been shown to exhibit multiple biological activities including anti-inflammatory, immunostimulating , antiviral , antioxidant , etc.
Moreover, polysaccharides are biodegradable materials expressing biocompatibility ; thus, they could represent as versatile tools for application in biomedical fields such as tissue engineering, drug delivery , prostheses and medical devices. İn the following sections, some examples of bioactive EPS, also listed in Table 10.1, are discussed in detail.
10.3.1 Anti-inflammatory/Immunomodulating
Inflammation is a complex and well-coordinated response of the innate and adaptive immune system following infection or injury. This process is characterised by a vascular response and recruitment of circulating leukocytes, defined initially by polymorphonuclear granulocytes followed by monocytes, which differentiate locally into macrophages. Host-defence mechanisms are divided into two distinct, but inextricably linked, pathways : the innate and the adaptive immune responses. The first one mounts a rapid response to injury by means of phagocytosis, production of reactive oxygen species (ROS) and release of cytokines, autacoids and lipid mediators that coordinate and amplify the local inflammatory response. On the contrary, the adaptive immune response mounts more slowly and furnishes a more focused response mechanism that requires the identification of specific molecular structures and depends on the generation of large numbers of antigen receptors (i.e. T-cell receptors and immunoglobulins). The resolution of inflammation occurs mainly via clearance of apoptotic cells by phagocytosis and by the production of anti-inflammatory mediators, such as IL-10 and TGF-β, in the lesion by tissue macrophages that phagocyted apoptotic cells.
An exopolysaccharide named EPS-1, containing tetrasaccharide-repeating units formed by sugars with a mannano-pyranosidic configuration, was isolated from a halophilic and thermotolerant Bacillus licheniformis strain (Table 10.1). EPS-1 was tested for its immunomodulatory effect by means of the production of different cytokines (IFN-α, IL-12; IFN-γ, TNF-α, IL-18) involved in the immune response in human peripheral blood mononuclear cells (PBMC) during the HSV-2 virus infection. Results showed that EPS-1 affected on cytokines production in a dose-dependent manner stimulating IFN-α production. Moreover, EPS-1 induced the production of IL-12 at considerable levels; IFN-γ and TNF-α were also detected (Arena et al. 2006). Later, Arena et al. (2009) (Table 10.1) reported the immunomodulatory and antiviral effects of an exopolysaccharide EPS-2, isolated from a strain of Geobacillus thermodenitrificans. EPS-2 also stimulated the cytokine production in PBMC cells in a concentration-dependent manner, like EPS-1. A high level of IL-12, IFN-γ, TNF-α and IL-18 was revealed after EPS-2 treatment (Arena et al. 2009).
Bacteria produce a high quantity of exopolysaccharides when they form biofilm, which is a consortium of microorganisms immobilised and penned within EPS that is able to limit the diffusion of substance and antimicrobial compounds. From the biofilm of the thermophilic bacteria Thermus aquaticus YT-1, a novel EPS named TA-1 with interesting immunomodulatory effects was isolated (Table 10.1). TA-1 stimulated macrophages cells to produce the cytokines TNF-α and IL-6 (Lin et al. 2011).
10.3.2 Antiviral
Pathogenesis is the process by which virus infection leads to disease. Pathogenic mechanisms include implantation of the virus at a body site, replication at that site and then spread to and multiplication within sites (target organs) where disease or shedding of virus into the environment occurs. Viruses cannot synthesise their genetic and structural components, and so they rely almost exclusively on the host cell for these functions. Pathogenesis at the cellular level can be viewed as a process that occurs in progressive stages leading to cellular disease. An essential aspect of viral pathogenesis at the cellular level is the competition between the synthetic needs of the virus and those of the host cell.
The antiviral activity linked to the immunoregulatory effect of bacterial polysaccharides was reported by Arena et al. (2006, 2009). In the first paper, the antiviral effect of a novel exopolysaccharide EPS-1 produced by a strain of thermotolerant Bacillus licheniformis (Table 10.1), isolated from a hot spring of Vulcano Island (Italy), has been reported. EPS-1 inhibited HSV-2 replication in PBMC (human peripheral blood mononuclear cells) by upregulating the expression of pro-inflammatory cytokines. In a later paper, an antiviral exopolysaccharide EPS-2, produced by a strain of Geobacillus thermodenitrificans, is reported. EPS-2 treatment in PBMC, at a concentration of 200 and 300 μg/mL, is affected on HSV-2 replication , in a concentration-dependent way, increasing the inflammatory response (Arena et al. 2009).
10.3.3 Application in Drug Delivery Systems
EPSs have the capacity to establish polymeric matrices. This ability enables their in vitro manipulation to create novel structures in which bioactive compounds are encapsulated, developing new applications in drug delivery systems.
Halomonas smyrnensis strain AAD6 (JCM 15723) (Table 10.1) was reported as a producer of high levels of levan exopolysaccharide. Studies on biocompatibility were performed, and the results exhibited that this levan did not affect cellular viability and proliferation of osteoblasts and murine macrophages. Moreover, the toxicity test carried out by Brine Shrimp Test showed a protective effect of levan against a toxic agent (Poli et al. 2009). Because of the amphiphilic nature of levan, it is able to form nanoparticles by self-assembly in water. The levan EPS isolated from strain AAD6 was studied for its potential use as a biopolymer in nanoparticle drug delivery system. Levan nanoparticles encapsulated with bovine serum albumin (BSA) were prepared and used as a model to investigate their different properties. The size of nanoparticles varied between 200 nm and 537 nm, and their encapsulation capacity also varied (ranged between 49.3% and 71.3%) depending on the levan concentration used. Moreover, the increasing in vitro release of BSA from the nanoparticles was displayed to be controlled release of proteins (Sezer et al. 2011).
10.4 Chemical and Structural Characterisation
The complete characterisation of an unknown EPS requires the definition of the polymer’s chemical composition and its structural analysis. The chemical composition is defined on the basis of the total carbohydrate content and of other molecules, such as proteins, and on the identification of the monosaccharide unit type of their relative molar ratio and of the presence of substituting groups. The structural analysis is defined by determining the sequence of glycosidic bonds and the possible tridimensional distribution of monomer components, i.e. the polysaccharide conformation. These tasks are accomplished by combining different analytical and instrumental techniques, i.e. chromatography, spectrometry and spectroscopy, which are used along all the steps of exopolysaccharide characterisation. The different methods and techniques required for the complete EPSs characterisation are listed in Table 10.2 and will be discussed in detail in the following sections.
10.4.1 Purification
The purification of EPSs is the first step of the study: usually intact cells are removed by heating the bacterial culture broth at 90–95 °C (in order to denature enzymes that hydrolyse the polysaccharide) followed by centrifugation. The EPS can be separated from the broth by means of precipitation (by adding alcohol or complexing metal ions) or ultrafiltration. The crude EPS obtained is then purified by combining different chromatography techniques, for example, gel filtration chromatography and anion-exchange chromatography. Usually the purified EPS is freeze-dried to be stored for long times in order to perform the chemical and structural characterisation.
10.4.2 Compositional Analysis
The gross chemical composition of an EPS is determined by measuring the total carbohydrate content, the protein and nucleic acid contents: the total carbohydrate content can be assessed by means of the Dubois method based on the use of phenol-sulphuric acid reagent; the total protein content is estimated using the Bradford method; finally the nucleic acids’ content is determined spectrophotometrically by measuring absorbance at λ 260 nm. Uronic acid content is another important chemical feature of EPS that can be determined according to the method described by Blumenkrantz and Asboe-Hansen (Spanò et al. 2013).
10.4.3 Determination of Monosaccharide Composition, Glycoside Linkage Position and Substituting Groups
The most common sugars that can be found as constituents of bacterial EPS include hexoses (d-glucose, d-galactose, d-mannose, d-allose, l-fucose, l-rhamnose), pentoses (d-ribose, d-arabinose, d-xylose), uronic acids (d-glucuronic, d-mannuronic and d-galacturonic acids) and amino sugars (d-glucosamine, d-galactosamine) . The nature and the molar ratio of the monosaccharides that constitute an EPS can be determined by chemolytic methods, i.e. total hydrolysis of EPS that is carried out at high temperature (up to 110–120 °C) in strong acidic conditions by using concentrated trifluoroacetic (TFA) or formic or sulphuric acids. The resulting hydrolysis mixture can be analysed after reduction followed by per-acetylation or silylation that converts the released monomer sugars in the respective volatile derivatives (alditol acetates or methylsilanes) that can be analysed by means of gas chromatography coupled with mass spectrometry (GC-MS). Alternatively, the hydrolysis mixture can be analysed without any derivatisation of monosaccharides, by means of liquid chromatography methods like the high-performance anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD), that is, a well-established method that allows either qualitative and quantitative analysis of monomer sugars released by acid. Chemolytic methods, for example, the methylation analysis (MA), are also employed for the determination of linkage positions . Commonly MA requires the following steps: methylation, by addition of methyl iodide; cleavage of glycosidic bonds, by classic acidic hydrolysis or by methanolysis (with methanolic HCl); reduction with NaBH4 followed by acetylation or silylation; and GC-MS analysis of the resulting mixture of volatile alditol acetates or methylsilanes. This treatment causes methylation of the free OH groups and acetylation or silylation only for the OH groups involved in the glycoside bonds: in such a way the position of glycosidic linkages will be identified as those corresponding to the non-methylated OH groups present in the alditol derivatives. Different organic and inorganic substituent groups can be present in the EPS that also significantly affect their chemical and biological properties. The most common organic substituents include ester-linked residues of acetate, succinate, propionate, glycerate and hydroxybutanoate, the ketal-linked pyruvate unit or amino acids like l-glutamate or serine. The most common inorganic substituents are sulphate and phosphate groups . The presence of the substituting groups can be assessed by means of Fourier transform-infrared spectroscopy (FT-IR) or nuclear magnetic resonance (NMR) (Mishra and Jha 2013).
10.4.4 Molecular-Weight Distribution
The molecular-weight (M w) distribution of an EPS is an important structural feature that often also affects biological activity of this kind of polymer. Different techniques can be employed for this purpose, for example, light scattering, sedimentation analysis in analytical ultracentrifugation, intrinsic viscosity determination, size-exclusion chromatography (SEC) or the more modern high-performance size-exclusion chromatography (HPSEC) techniques with refractive index (RI) detection or multi-angle laser light scatter (MALLS) detection.
Light scattering allows to measure the absolute M w using the relationship, stated by the Rayleigh theory, between the intensity of light scattered by a molecule and its molecular weight and size. Sedimentation analysis is based on the determination of sedimentation velocity of polysaccharides during ultracentrifugation: the value of M w is deduced from the changes in the refractive index of the polysaccharide solution when it is subjected to high force fields. The measure of the intrinsic viscosity η is used for M w determination at infinite dilution. In such conditions, η is a function of the average molecular weight (M w) and can be calculated by means of the Mark-Houwink-Sakurada equation η = K M w α where K and α are constants for a given polymer/solvent/temperature system .
Size-exclusion chromatography (SEC) is widely employed for the M w characterisation of different kinds of polymers . This technique is based on the use of soft gels, for example, Sepharose CL-4B or porous polystyrene-divinylbenzene resins, and the M w is calculated by comparison with external standard calibration curves derived by using pullulans and dextrans as standard polymers. Significant improvements in the use of this technique have been achieved by coupling with online detectors like light-scattering detectors and viscometers. More recent developments of SEC are represented by high-performance size-exclusion chromatography (HPSEC) technique using online detectors like refractive index (RI) or multi-angle laser light scatter (MALLS) detectors. Although widely used, such methods present some major drawbacks like longer time of analysis and need of higher amount of samples. For such reasons the use of HPSEC methods is emerging since they afford faster analyses and requires smaller quantities of samples. HPSEC columns are made of rigid matrixes of small porous silica microspheres as such or bonded with glycerylpropyl groups, of agarose or methacrylate polymers. The online detection is often performed with RI, a universal detector that is useful for the determination of M w distribution since there is a linear correlation between the EPS concentration and its M w. Nevertheless, higher accuracy can be achieved by using a MALLS detector that allows the absolute determination of M w that is based on the calculation of the amount of scattered light at each angle detected, thus not requiring external calibration curves (Gómez-Ordonez et al. 2012).
10.4.5 Structural Analysis by NMR and FT-IR Techniques
NMR spectroscopy is a useful tool for the determination of both polysaccharides’ composition and conformation. The structure elucidation of EPSs relies on the use of both 1D and 2D 1H- and 13C-NMR techniques and of relevant databases such as Carb-Bank, SUGABASE or CASPER. Indeed 1H and 13C chemical shift and coupling constant values are available in literature for many monosaccharides and can be used for assignment of polysaccharide resonances. 1D 1H and 13C techniques can afford a good estimation of the number of sugar residues present in an EPS: identification and integration of signals in the anomeric region of 1H, corresponding to δ 4.4 – 5.5 ppm, can give such an information that is confirmed by the analysis of the anomeric region of 1D-13C spectrum. Alternatively, this information can be gained by applying 2D heteronuclear techniques like HSQC, HMQC or HMBC that are more sensitive than single mono-dimensional analysis since they can resolve complex signal patterns that usually characterise the anomeric region of 1H spectrum. The following step is represented by the determination of the type of monosaccharides that constitute the EPS that can be identified by means of two-dimensional homonuclear and heteronuclear techniques since the typical chemical shift values and J-coupling patterns of most monosaccharides are listed in several databases. The homonuclear TOCSY or DQF-COSY spectra afford information on the spin system of single monosaccharides: such techniques allow resolution of the so-called bulk region of 1H spectrum in which usually the resonance relatives to non-anomeric protons strongly overlap. The 13C shift values relative to such protons are then easily deduced by comparison with HSQC or HMBC spectra. NMR can also be used for assignment of anomeric configuration since usually the β-anomers of pyranose sugars resonate at higher field than the corresponding α-isomers; in addition the calculation of direct coupling constant 1H–13C for the anomer proton (J C1,H1) can also be useful, since usually its value is about 170 Hz for the α-anomeric sugars, while for the β forms it is ~ 160 Hz.
The sequence of the monosaccharide residues within the EPS can also be achieved by means of 2D techniques like NOESY and HMBC. In particular, NOESY spectrum allows to identify NOEs (nuclear Overhauser effects) between signals belonging to directly linked monosaccharide residues, thus affording information on glycosidic linkages sequence along the polysaccharide backbone.
Finally, NMR can be used for identification of substituents since the signals of most organic groups, for example, acyl or methyl groups, do not overlap to carbohydrate resonances, being found in high field regions at about 0.2–0.5 ppm. On the other hand, the presence of inorganic groups like phosphates can be assessed by means of heteronuclear 31P–1H long-range coupling measurements. The interpretation of such complex data can be supported by the use of software programmes, for example, PRONTO freely available at this link: http://www.crc.dk/chem/pronto/welcome.html (Duus et al. 2000).
Fourier transform-infrared spectroscopy (FT-IR) is another spectral technique that can be applied to EPS structural investigation. Indeed some typical signals support polysaccharide recognition like the signals in the fingerprint region, i.e. below 1500 cm−1, where broad stretching bands relative to C–O–C and C–O (at 1700 cm−1) ring bonds and C–H bending (at 1410 cm−1) are typically found; like the stretching peak of hydroxyl groups (usually at around 3300 cm−1); or, finally, like the signals around 2900 cm−1 attributable to the C–H stretching of either methyl or methylene groups.
10.5 Conclusions and Future Perspectives
EPSs are extracellular biopolymers produced by many extremophilic microorganisms that use them as a valuable adaptation strategy to extreme environmental conditions. EPSs protect extremophiles from the deleterious effects of extreme pH , temperature , salt concentration or radiation by forming capsular materials or dispersed biofilm in the surrounding environment. Indeed, several extremophiles, isolated either from aquatic or terrestrial environments , have been shown to be EPSs producers. Notably, these biopolymers represent a promising class of compounds for applications in several fields, i.e. pharmaceutical, food or biotechnology sectors since they possess interesting properties, for example, biological and biotechnological properties. Indeed several examples of bioactive EPSs acting as anti-inflammatory, immunomodulating or antiviral agents are described in literature. Other promising applications in the pharmaceutical fields are as dug delivers or as vaccine adjuvants . Moreover thanks to their features they can act as metal binders , thus affording a valuable tool for bioremediation processes, or as biosurfactant or bioemulsifier , thanks to their rheological properties like viscosity or thermostability. Many other possible applications can be found for extremophiles EPSs that in future could play a pivotal role in biotechnology.
Take-Home Message
-
EPSs are produced by several extremophilic microorganisms, belonging to both Archaea and Bacteria domains that have been isolated from different ecosystems.
-
The biosynthesis of EPSs can take place either into the cell or in the extracellular milieu; it follows three main routes, all regulated by a group of enzymes named ‘glycosyltransferases’.
-
The genetic manipulation of the EPSs’ producing bacteria has been employed to optimise the yield of and for tailoring polymers’ chemical composition and structure.
-
The structural characterisation of EPSs requires a combination of analytical and instrumental techniques that include chromatography, IR spectroscopy, 1D and 2D NMR (1H NMR/13C NMR).
-
The extremophiles’ EPSs possess unique properties that can be exploited for a variety of biological and biotechnological applications.
References
Arco Y, Llamas I, Martınez-Checa F, Argandona M, Quesada E, del Moral A (2005) epsABCJ genes are involved in the biosynthesis of the exopolysaccharide mauran produced by Halomonas maura. Microbiology 151(9):2841–2851
Arena A, Maugeri TL, Pavone B, Iannello D, Gugliandolo C, Bisignano G (2006) Antiviral and immunoregulatory effect of a novel exopolysaccharide from a marine thermotolerant Bacillus licheniformis. Int Immunopharmacol 6(1):8–13
Arena A, Gugliandolo C, Stassi G, Pavone B, Iannello D, Bisignano G, Maugeri TL (2009) An exopolysaccharide produced by Geobacillus thermodenitrificans strain B3-72: antiviral activity on immunocompetent cells. Immunol Lett 123(2):132–137
Ateş Ö, Toksoy Öner E, Arga KY (2011) Genome-scale reconstruction of metabolic network for a halophilic extremophile, Chromohalobacter salexigens DSM 3043. BMC Syst Biol 5:12
Ateş Ö, Arga KY, Toksoy Öner E (2013) The stimulatory effect of mannitol on levan biosynthesis: lessons from metabolic systems analysis of Halomonas smyrnensis AAD6(T). Biotechnol Prog 29:1386–1397
Duus JO, Gotfredsen CH, Bock K (2000) Carbohydrate structural determination by NMR spectroscopy: modern methods and limitations. Chem Rev 100:4589–4614
Finore I, Di Donato P, Mastascusa V, Nicolaus B, Poli A (2014) Fermentation technologies for the optimization of marine microbial exopolysaccharide production. Mar Drugs 12:3005–3024. https://doi.org/10.3390/md12053005
Freitas F, Alves VD, Reis M (2011) Advances in bacterial exopolysaccharides: from production to biotechnological applications. Trends Biotechnol 29(8):388–398. https://doi.org/10.1016/j.tibtech.2011.03.008
Gómez-Ordonez E, Jiménez-Escrig A, Rupérez P (2012) Molecular weight distribution of polysaccharides from edible seaweeds by high-performance size-exclusion chromatography (HPSEC). Talanta 93:153–159
Kambourova M, Mandeva R, Dimova D, Poli A, Nicolaus B, Tommonaro G (2009) Production and characterization of a microbial glucan, synthesized by Geobacillus tepidamans V264 isolated from Bulgarian hot spring. Carbohydr Polym 77(2):338–343
Lin MH, Yang YL, Chen YP, Hua KF, Lu CP, Sheu F, Lin GH, Tsay SS, Liang SM, Wu SH (2011) A novel exopolysaccharide from the biofilm of Thermus aquaticus YT-1 induces the immune response through Toll-like receptor 2. J Biol Chem 286(20):17736–17745. https://doi.org/10.1074/jbc.M110.200113
Llamas L, Mata JA, Tallon R, Bressollier P, Urdaci MC, Quesada E, Bejar V (2010) Characterization of the exopolysaccharide produced by Salipiger mucosus A3T, a halophilic species belonging to the Alphaproteobacteria, isolated on the Spanish Mediterranean seaboard. Mar Drugs 8(8):2240–2251
Mancuso Nichols CA, Garon S, Bowman JP, Raguénès G, Guézennec J (2004) Production of exopolysaccharides by Antarctic marine bacterial isolates. J Appl Microbiol 96:1057–1066. https://doi.org/10.1111/j.1365-2672.2004.02216.x
Mastascusa V, Romano I, Di Donato P, Poli A, Della Corte V, Rotundi A, Bussoletti E, Quarto M, Pugliese M, Nicolaus B (2014) Extremophiles survival to simulated space conditions: an astrobiology model study. Orig Life Evol Biosph 44(3):231–237
Mishra A, Jha B (2013) Microbial exopolysaccharides. In: Rosenberg E et al (eds) The prokaryotes – applied bacteriology and biotechnology. Springer, Berlin, pp 179–192. https://doi.org/10.1007/978-3-642-31331-8_25
Nicolaus B, Kambourova M, Toksoy Oner E (2010) Exopolysaccharides from extremophiles: From fundamentals to biotechnology. Environ Technol “Special Issue Extremophiles” 31(10):1145–1158
Poli A, Kazak H, Gurleyendag B, Tommonaro G, Pieretti G, Toksoy Oner E, Nicolaus B (2009) High level synthesis of levan by a novel Halomonas species growing on defined media. Carbohydr Polym 78(4):651–657
Poli A, Anzelmo A, Nicolaus B (2010) Bacterial exopolysaccharides from extreme marine habitats: production, characterization and biological activities. Mar Drugs 8(6):1779–1802
Poli A, Di Donato P, Abbamondi GR, Nicolaus B (2011) Synthesis, production, and biotechnological applications of exopolysaccharides and polyhydroxyalkanoates by archaea. Archaea 2011:693253. https://doi.org/10.1155/2011/693253
Qin QL, Zhang XY, Wang XM, Liu GM, Chen XL, Xi BB, Dang HY, Zhou BC, Yu J, Zhang YZ (2010) The complete genome of Zunongwangia profunda SM-A87 reveals its adaptation to the deep-sea environment and ecological role in sedimentary organic nitrogen degradation. Genomics 11:247. https://doi.org/10.1186/1471-2164-11-247
Sezer AD, Kazak H, Toksoy E, Akbuga J (2011) Levan-based nanocarrier system for peptide and protein drug delivery: optimization and influence of experimental parameters on the nanoparticle characteristics. Carbohydr Polym 84(1):358–363
Spanò A, Gugliandolo C, Lentini V, Maugeri TL, Anzelmo G, Poli A, Nicolaus B (2013) A novel EPS-producing strain of Bacillus licheniformis isolated from a shallow vent off Panarea Island (Italy). Curr Microbiol 67:21–29. https://doi.org/10.1007/s00284-013-0327-4
Stingele F, Neeser JR, Mollet B (1996) Identification and characterization of the eps (exopolysaccharide) gene cluster from Streptococcus thermophilus Sfi6. J Bacteriol 178:1680–1690
Yasar Yildiz S, Anzelmo A, Ozer T, Radchenkova N, Genc S, Di Donato P, Nicolaus B, Toksoy Oner E, Kambourova M (2014) Brevibacillus themoruber: a promising microbial cell factory for exopolysaccharide production. J Appl Microbiol 116:314–324. https://doi.org/10.1111/jam.12362
Acknowledgements
This work was partially supported by the project PON03PE_00107_1 BioPoliS ‘Sviluppo di tecnologie verdi per la produzione di BIOchemicals per la sintesi e l’applicazione industriale di materiali POLImerici a partire da biomasse agricole ottenute da sistemi colturali Sostenibili nella Regione Campania’.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Di Donato, P., Poli, A., Tommonaro, G., Abbamondi, G.R., Nicolaus, B. (2018). Exopolysaccharide Productions from Extremophiles: The Chemical Structures and Their Bioactivities. In: Sani, R., Krishnaraj Rathinam, N. (eds) Extremophilic Microbial Processing of Lignocellulosic Feedstocks to Biofuels, Value-Added Products, and Usable Power. Springer, Cham. https://doi.org/10.1007/978-3-319-74459-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-74459-9_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74457-5
Online ISBN: 978-3-319-74459-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)